MENU
JUN 17, 2020 3:00 PM PDT

Surgery as (Un)Usual: Development of Rodent Intracerebroventricular injection Capabilities During COVID-19

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Senior Manager InVivo Sciences, Charles River
    Biography
      Matt entered the research field almost 30 years ago as a lab animal technician at the TSI/Mason contract research facility in Worcester, Massachusetts. Since then, he has worked in laboratory contract facilities such as Primedica and OREAD Biosafety, as well as within the biotech/pharma industry at Pharmacia, Pfizer, Genzyme/Sanofi-Aventis, and Biogen. Matt joined Charles River Laboratories last year as the senior manager of the In Vivo Sciences department at their Shrewsbury, Massachusetts facility. During his career, Matt has performed a variety of surgical procedures including device implantation, organ transplants, orthopedic defect, ocular and vascular implants, cardiac procedures, fibrosis modelling and brain and spinal procedures. His experience ranges from mice and rats to non-human primates and livestock. He holds patents for novel surgical devices and implants and has been training technicians, scientists, veterinarians, and physicians in surgical techniques and procedures for over 20 years. He is currently also an adjunct professor at the Worcester Polytechnic Institute, teaching the graduate-level Laboratory Animal Surgery course. Outside of the surgical realm, he has been a toxicology and pharmacology study director, cardiac sonographer, safety pharmacology scientist, and manager. Currently, Matt manages a team of over 70 technicians, trainers, data reviewers, team leaders, and supervisors. Matt served on the board of directors for the Academy of Surgical Research for over ten years, including as the program chair for three years and the educational chair for two years. He is the current president for the New England branch of AALAS.

    Abstract

    Bringing a new research surgical model into production is always a challenging endeavor, and it has become much more challenging with the emergence of the Covid-19 pandemic. The virus’s impact on supply chains, personnel and other resources, and the effects of stress and uncertainty on the people involved forced creativity and in many cases brought the best from these same people. In this presentation, we will discuss the obstacles that we faced and how we ultimately overcame them, along with lessons learned for future rounds of this pandemic.

    Learning Objectives:
    1. Participants will learn of some of the hidden and unexpected pitfalls in supply chains during the pandemic

    2. Participants will learn of specific fast response accommodations made to protect personnel during the pandemic


    Show Resources
    You May Also Like
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    SEP 17, 2020 2:00 PM PDT
    C.E. CREDITS
    SEP 17, 2020 2:00 PM PDT
    Learning Objectives: 1. Understanding the integral value of collaboration for advancement in scientific research; how to establish and grow academic, Pharma, and industry connections 2. Lear...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    JUN 17, 2020 12:00 PM PDT
    C.E. CREDITS
    JUN 17, 2020 12:00 PM PDT
    The 2020 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to rage. While PCR-based assays are used for viral diagnosis, high through-put, rapid s...
    Loading Comments...
    Show Resources
    Attendees
    • See more